These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18216082)

  • 1. Subcutaneous sufentanil for palliative care patients in a hospital setting.
    White C; Hardy J; Boyd A; Hall A
    Palliat Med; 2008 Jan; 22(1):89-90. PubMed ID: 18216082
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing high dose sufentanil in a suffering patient.
    Walker PW; Bruera E; Boohene J
    J Pain Symptom Manage; 2008 Jul; 36(1):e1-4. PubMed ID: 18538537
    [No Abstract]   [Full Text] [Related]  

  • 3. Intranasal sufentanil for cancer-associated breakthrough pain.
    Good P; Jackson K; Brumley D; Ashby M
    Palliat Med; 2009 Jan; 23(1):54-8. PubMed ID: 19144765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical morphine for cutaneous cancer pain.
    Krajnik M; Zylicz Z
    Palliat Med; 1997 Jul; 11(4):325. PubMed ID: 9373587
    [No Abstract]   [Full Text] [Related]  

  • 5. Methadone: a closer look at the controversy.
    Gaertner J; Voltz R; Ostgathe C
    J Pain Symptom Manage; 2008 Aug; 36(2):e4-7. PubMed ID: 18655953
    [No Abstract]   [Full Text] [Related]  

  • 6. Pupillary response in patients receiving intrathecal sufentanil.
    Wang YC; Guo QL; Wang E; Zhong T; Huang CS; Peng J
    Chin Med J (Engl); 2007 Jul; 120(14):1274-6. PubMed ID: 17697584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controlling symptoms as early as possible. Palliative medicine is not the final anointment].
    Bischoff A
    MMW Fortschr Med; 2004 Oct; 146(42):14. PubMed ID: 15536698
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronogesic (DURECT).
    Joshi GP
    IDrugs; 2003 Apr; 6(4):368-71. PubMed ID: 12789608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Continuous subcutaneous infusion in palliative care, an undervalued method].
    Keijer WJ; de Jong RJ
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):318-9; author reply 319. PubMed ID: 12622011
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposed FDA rules on painkillers in U.S. Rile cancer community.
    Brower V
    J Natl Cancer Inst; 2009 Oct; 101(20):1376-7. PubMed ID: 19797722
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictive factors of severe postoperative pain in the postanesthesia care unit.
    Aubrun F; Valade N; Coriat P; Riou B
    Anesth Analg; 2008 May; 106(5):1535-41, table of contents. PubMed ID: 18420872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partnering with palliative care.
    Snapp J
    Nurs Manage; 2010 Jan; 41(1):18-23; quiz 23-4. PubMed ID: 20035196
    [No Abstract]   [Full Text] [Related]  

  • 13. [Continuous subcutaneous treatment of pain in terminal cancer patients].
    Drøsdal S
    Tidsskr Nor Laegeforen; 1984 Sep; 104(25):1720-1. PubMed ID: 6207606
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidural sufentanil provides better analgesia from 24 h after surgery compared with epidural fentanyl in children.
    Cho JE; Kim JY; Kim JE; Chun DH; Jun NH; Kil HK
    Acta Anaesthesiol Scand; 2008 Nov; 52(10):1360-3. PubMed ID: 19025528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion sufentanil for malignant pain: a case report.
    Anderson R; Saiers RJ; Schlicht C; Abram S
    Am J Hosp Palliat Care; 2000; 17(4):265-8. PubMed ID: 11883803
    [No Abstract]   [Full Text] [Related]  

  • 16. Prescribing of pain medication in palliative care. A survey in general practice.
    Borgsteede SD; Deliens L; Zuurmond WW; Schellevis FG; Willems DL; Van der Wal G; van Eijk JT
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):16-23. PubMed ID: 18985638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled sedation for refractory symptoms in dying patients.
    Mercadante S; Intravaia G; Villari P; Ferrera P; David F; Casuccio A
    J Pain Symptom Manage; 2009 May; 37(5):771-9. PubMed ID: 19041216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical use of sufentanil].
    Toftegaard M; Pedersen PF; Hansen PA; Knudsen F
    Ugeskr Laeger; 1996 Jun; 158(24):3483-6. PubMed ID: 8650823
    [No Abstract]   [Full Text] [Related]  

  • 19. [Palliative pain relief].
    Pedersen L; Maagaard R
    Ugeskr Laeger; 2004 Aug; 166(32):2675. PubMed ID: 15347172
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of epidural ropivacaine 0.2% and ropivacaine 0.2% in combination with sufentanil 0.75 microg mL-1 for postcaesarean analgesia.
    Kaya T; Büyükkoçak U; Başar H; Sağsöz N
    Agri; 2008 Oct; 20(4):30-7. PubMed ID: 19117154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.